Safety Study of IgAN, LN, MN, & C3 Glomerulopathy Including Dense Deposit Disease Treated With OMS721
Clinical trial NCT02682407 · TERMINATED
Trial details
- NCT number
- NCT02682407
- Sponsor
- Omeros Corporation
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-10
- Primary completion
- 2020-08-25
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.